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Abstract
Purpose A 30 year-old man with a history of recurrent skin
infections as well as elevated serum IgE and eosinophils
developed neurological symptoms and had T2-hyperintense
lesions observed in cerebral MRI. The immune symptoms
were attributed to Hyper IgE syndrome (HIES) and the neu-
rological symptomswith presence of JC virus in cerebrospinal
f luid were diagnosed as Progressive Mult i focal
Leukoencephalopathy (PML). The patient was negative for
STAT3 mutations. To determine if other mutations explain
HIES and/or PML in this subject, his DNAwas analyzed by
whole genome sequencing.
Methods Whole genome sequencing was completed to 30X
coverage, and whole genome SNP typing was used to com-
plement these data. The methods revealed single nucleotide
variants, structural variants, and copy number variants across
the genome. Genome-wide data were analyzed for homozy-
gous or compound heterozygous null mutations for all protein
coding genes. Mutations were confirmed by PCR and/or
Sanger sequencing.
Results Whole genome analysis revealed deletions near the
telomere of both copies of chromosome 9p. Several genes,
including DOCK8, were impacted by the deletions but it was
unclear whether each chromosome had identical or distinct
deletions. PCR across the impacted region combined with
Sanger sequencing of selected fragments confirmed a homo-
zygous deletion from position 10,211 to 586,751.
Conclusion While several genes are impacted by the deletion,
DOCK8 deficiency is the most probable cause of HIES in this
patient. DOCK8 deficiency may have also predisposed the
patient to develop PML.
Keywords Hyper IgE Syndrome . DOCK8 deficiency .
primary immune deficiency . ProgressiveMultifocal
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The hyper IgE syndromes (HIES) are rare primary immuno-
deficiencies characterized by elevated serum IgE, dermatitis
and recurrent skin and lung infections [1, 2]. There are two
forms of HIES that are characterized based on their inheri-
tance patterns: autosomal-dominant HIES (AD-HIES) and
autosomal-recessive HIES (AR-HIES). AD-HIES is caused
by dominant mutations in STAT3 and is characterized in
addition to the symptoms noted above by extra-immune man-
ifestations including skeletal, connective tissue and vascula-
ture abnormalities [1, 2]. AR-HIES is caused by homozygous
or compound heterozygous mutations in DOCK8, TYK2 or
STK3, and these patients do not possess any of the extra-
immune manifestations found in AD-HIES [3–6]. The major
manifestations of DOCK8 deficiency leading to AR-HIES are
recurrent viral and bacterial infections starting early in life,
extreme eosinophilia, and elevated IgE levels. The causes of
DOCK8 deficiency thus far described range from point
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mutations and small indels to large deletions of portions of
DOCK8 preventing expression of the protein [3–6]. This
report adds to the growing body of knowledge about
DOCK8-deficient AR-HIES and discovers the largest pub-
lished deletion in the region around DOCK8. In addition, we
add to the literature showing the occurence of Progressive
Multifocal Leukoencephalopathy in DOCK8 deficient
individuals.
A 30 year old, male, Caucasian patient suffering from
eczematoid dermatitis developed impetiginization of the skin
with Klebsiella pneumonia and group A β-hemolytic strepto-
coccus species in July, 2008. The patient was diagnosed with
HIES based on elevated serum IgE (26,800 kU/L) and elevat-
ed eosinophils (1.6×109 /L). The patient had atopic dermatitis
that was treated with topical corticosteroids and recurrent
herpesviral skin infections from the age of 6 years. There were
no reports of any other immunosuppressive agents. The pa-
tient history revealed that his parents were first cousins, how-
ever, no immunological diseases, opportunistic infection or
childhood diseases were reported in the parent’s siblings or
their children. In September, 2008 the patient developed a left-
sided sensory hemisyndrome, which progressed to a spastic-
atactic hemiparesis within a few weeks. A cerebral MRI
showed a large confluent T2-hyperintense lesion in the frontal
parietal central region of the right cerebral hemisphere, a small
T2-hyperintense lesion in the right temporal cortex, and small
T2-hyperintense lesions in the right cerebellar heimisphere. In
October, 2008 the cerebrospinal fluid (CSF) of the patient was
positive for JC polyoma virus DNA (500 copies/mL) leading
t o t h e d i a g n o s i s o f P r o g r e s s i v e Mu l t i f o c a l
Leukoencephalopathy (PML). Peripheral blood analysis
showed repeatedly highly increased numbers of IgE
(12,166–26,800 kU/l) and eosinophils (3,066–6,068/ul) and
decreased levels of lymphocytes (296–770/ul), CD3+ T cells
(130–265/ul), CD4+ T cells (71–169/ul), CD8+ T cells (29–
109/ul), CD19+ B cells (173–262/ul) and NK cells (10–81/ul)
(Table S1). After stimulation of lymphocytes with phytohe-
magglutinin, CD3+ Tcells responded adequately as shown by
intracellular production of interferon-γ (24 % of cells),
interleukin-2 (25.6 %) and tumor necrosis factor-α (11.2 %).
A screen for STAT3 mutations in April, 2009 was negative.
The family history of first cousin parents and the absence of
STAT3 mutations lead to the refined diagnosis of AR-HIES of
unknown etiology. In August 2009, antiepileptic treatment
with 3,000 mg levetiracetam and 100 mg pregabaline daily
was started because of focal sensory epileptic seizures in the
left hemibody. MRI follow-up showed a reduced size of the
T2-lesion within the right cerebral central region, but CSF
JCV DNA copy number had increased tenfold (5,200 JCV
genomic copies/mL). Until December 2010, neurological def-
icits had progressed only mildly, but MRI showed dissemina-
tion and enlargement of the PML lesions in the left thalamic
region, left hemisphere, pons, and the right cerebellar
pedunculus. The patient’s DNA was sent for whole-genome
Fig. 1 Deletion of DOCK8 in a
patient with HIES and PML. A.
Telomeric region of chromosome
9p showing the deleted region and
the impacted genes. B.
Hypothetical ploidy observed in
whole genome sequence. Note
apparent single copy coverage
near the telomere, then nearly
500 kb with no coverage, and
then diploid coverage starting at
approximately 586,000 bases.
The letters a,b,c and d show the
approximate location of PCR
primers used to confirm the nature
of the deletion. C. Results of PCR
using the primers shown in 1B.
Gel a: lanes 1,2, and 4 are
controls, lane 3 is the HIES
subject. Gels b, c and d: lane 1 is
the HIES subject, lanes 2 and 3
are control subject, lane 4 is a no
template control. Primer sets a, b,
and c produce bands from the
controls but not from the HIES
subject, and primer set d only
produces a band from the HIES
subject
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SNP analysis and sequencing in April, 2012. After this the
patient was not available for follow-up of the disease course.
The patient’s DNAwas whole genome sequenced (WGS)
by Complete Genomics Incorporated (CGI; software version
2.0) [7, 8] and was analyzed on the Illumina Omni 1 quad
genome-wide SNP array. The WGS approach used short (31–
35 base) sequence reads at >30X coverage mapped to the
reference genome using methods previously described [7] to
identify single nucleotide, copy number, and structural vari-
ants. Relative to the reference genome, the sequence of this
individual included 19435 missense variants, 178 nonsense
variants, 470 frameshift variants, and >100 copy number and
structural variants. Single nucleotide variants (SNVs) were
analyzed using the ENSEMBL Variant Effect Predictor v2.8
[9] on the ENSEMBL v70 database, and variant effects on the
annotated canonical transcripts for all genes were assessed via
PolyPhen2 [10] and SIFT [11]. A variant was considered
possibly damaging if it was determined to be either ‘probably
damaging’ or ‘possibly damaging’ by PolyPhen2 or ‘delete-
rious’ by SIFT. We examined known genes associated with
immune deficiency, including the HIES genes STAT3, TYK2,
STK3 and DOCK8, and observed no damaging mutations in
STAT3 or STK3, heterozygosity for a possibly damaging
missense variant in TYK2 (rs147991080, R448W, MAF
<0.01 (http://browser.1000genomes.org/); Table S2), and
large deletions on both copies of chromosome 9p in the
region that includes DOCK8. The SNP array data also
suggested a large deletion on chromosome 9p, with mostly
non-called SNPs from approximately 194,000 to 600,000
bases (Table S3). Given the heterozygosity and ambiguous
function of the TYK2 variant and the obvious deletions
around DOCK8, it is clear that the DOCK8 mutation(s) con-
tribute to the patient’s disease.
The WGS and SNP data were not clear on the exact
deletion breakpoints or whether the patient was homozygous
for the same deletion or had inherited two different deletions.
Table 1 Genes in the deleted interval on chromosome 9, with Gene Ontology (GO;([24, 25]) biological process and function annotation, as well as
associated phenotypes in Online Medelian Inheritance in Man (OMIM; http://omim.org/)
Gene Symbol GO biological process GO function OMIM phenotypes
(MIM number)





























CBWD1 None GO:0000166:nucleotide binding
GO:0005524:ATP binding
None










GO:0061485:memory T cell proliferation
GO:0070233:negative regulation









KANK1 None None Cerebral palsy, spastic
quadriplegic, 2 (612900)
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The WGS CNVanalysis estimated that the patient was homo-
zygous null for DOCK8 and some of KANK1, but could be
hemizygous towards the telomere encompassing CBWD1,
FOXD4, FAM138C, WASH1, and DDX11L5 (Fig. 1 panels
A,B), and was consistent with the hypothesis that the patient
had some DNA telomeric to DOCK8. The WGS analysis of
the p-arm from the telomere to the DOCK8 locus is compli-
cated by a segmental duplication that results in extremely high
sequence similarity to Chromosome 2 [12, 13] and ambiguous
sequence assembly. To resolve the breakpoints for the indi-
vidual’s deletion(s) we designed targeted PCR around SNPs
rs12353065, rs7853676 and rs11794423 which theWGS SNP
analysis called high confidence SNPs, theWGSCNVanalysis
estimated to be hemizygous, and PCR primers unique to
chromosome 9 could be designed (Fig. 1 panels B,C). Figure 1
panel C shows that the PCR with primers for the 3 SNPs (gels
a, b and c) are all negative illustrating that the patient is in fact
homozygous null from around the telomere into KANK1. To
resolve the exact breakpoints we designed PCR primers close
to the telomere and in KANK1 (PCR pair d Fig. 1 panel B,C).
Upon the successful amplification of this fragment we cloned
the DNA and Sanger sequenced the fragment.We performed a
global gapped alignment with the Needleman-Wunsch algo-
rithm of the resulting DNA fragment to chromosome 9 from
bases 1-700,000 (NC_000009.11) and it revealed the align-
ment in Supplementary Figure 1. The alignment shows a
massive homozygous deletion from position 10,211 to
586,751 that makes the patient homozygous null for the genes
WASH1, FAM138C, FOXD4, CWBD1, C9orf66, DOCK8
and most of KANK1.
DOCK8 deficiency is the most likely cause of HIES in this
subject, and may have predisposed him to the development of
PML. Among the genes in the deletion interval none of the
other genes are so obviously connected to the phenotype
(Table 1), and elsewhere in the genome there are no mutations
consistent with known inheritance patterns for HIES. Notably,
this is not the first case report of PML in DOCK8 deficiency
[14]. PML has been observed in a limited subset of PIDs that
includes DOCK8 deficiency, Wiskott-Aldrich Syndrome,
STAT1 gain of function mutations and CD40L deficiency
[15–20]. This observation highlights a new pathway by which
the ubiquitous JC virus causes PML in a small fraction of
individuals and further demonstrates the utility of whole ge-
nome sequencing for diagnosing diseases of unknown etiolo-
gy. DOCK8 deficiency can be treated by bone marrow trans-
plantation [21–23], and the possibility of PML in these indi-
viduals is a reason to consider early and accurate diagnosis of
suspect cases by genetic analysis and treatment by
transplantation.
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